Cargando…
Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
BACKGROUND: Aspartate β-hydroxylase (ASPH) is an embryonic transmembrane protein aberrantly upregulated in cancer cells, associated with malignant transformation and, in some reports, with poor clinical prognosis. OBJECTIVE: To report the expression patterns of ASPH in acute myeloid leukemia (AML)....
Autores principales: | Holtzman, Noa G., Lebowitz, Michael S., Koka, Rima, Baer, Maria R., Malhotra, Kanam, Shahlaee, Amir, Ghanbari, Hossein A., Bentzen, Søren M., Emadi, Ashkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727599/ https://www.ncbi.nlm.nih.gov/pubmed/35004304 http://dx.doi.org/10.3389/fonc.2021.783744 |
Ejemplares similares
-
Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas
por: Sturla, Lisa-Marie, et al.
Publicado: (2016) -
Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)
por: Biswas, Biswajit, et al.
Publicado: (2013) -
Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH
por: Fuller, Steven, et al.
Publicado: (2013) -
Promyelocytic sarcoma of the right humerus: an unusual clinical presentation with unique diagnostic and treatment considerations
por: Sawhney, Sameer, et al.
Publicado: (2017) -
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway
por: Zou, Qifei, et al.
Publicado: (2018)